News

Sir David Amess MP, 1952-2021

Our Patron, Sir David Amess MP, was a great friend to the Alliance for Human Relevant Science, as well as to Safer Medicines. We are all devastated by his tragic loss and send our heartfelt condolences to his family. The volume of tributes being paid to Sir David goes to show what a wonderfully kind, caring and delightful human being he was.

He was a prominent spokesperson on health issues and served for 10 years on the House of Commons Health Select Committee. In 2012, he received the “Outstanding Achievement Award” at the Charity Champion Parliamentary reception, in recognition of his lifetime commitment to charitable work. He was a powerful champion of many good causes and had an unequalled backbench record for introducing new bills into law.

Sir David supported our work for many years, and on becoming our Patron, he said: “I am passionate about both human health and animal welfare, and I applaud Safer Medicines Trust for showing that there is no contradiction between the two, as we are so often led to believe.”

He features in this 5 minute video from 2011 of our petition hand-in to Number 10: https://www.youtube.com/watch?v=XcG2UgvVbV0 and in this 3 minute video from 2017 of the launch of the Alliance for Human Relevant Science: https://www.humanrelevantscience.org/launch-event/

We are so honoured and grateful to have had his invaluable support and we will miss him terribly.

Share
Follow Us

Latest Blog Posts

More harm than good? We need to talk about this!

As a patient safety charity whose raison d’etre is to reduce adverse drug reactions, Safer Medicines Trust is deeply concerned by the incidence of adverse reactions following covid-19 vaccinations. This is not what anyone wanted, following their remarkable development with such unprecedented speed – but it is certainly something that health systems should have been on high […]

‘Five For Friday’; Starting 2022 with five examples of human-relevant science using new approach methodologies (NAMs)

By Rebecca Ram Many research methods which focus on human-relevant biology (NAMs) are in use worldwide. However, a co-ordinated analysis of all existing methods that could be harmonised for global regulatory approval, as well as diversion of funding to the development of new methods are both long overdue. Encouraging signs were seen in Europe towards […]